PET scan safety study with [18F]-Fluoromannitol in healthy volunteers
This study tests a new radioactive tracer called [18F]-Fluoromannitol for PET scans in healthy adults. It checks how the tracer moves in the body and if it's safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are generally healthy with no active infections or recent serious illnesses.
- You do not have any chronic diseases like lung, liver, kidney, or autoimmune conditions that cause inflammation.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have any medical implants or devices like a pacemaker or joint replacement.
- You are not taking medications that interact with mannitol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new PET imaging agent (a radioactive tracer used in medical imaging) to understand how it moves through the body and the radiation dose it delivers. Researchers need healthy volunteers to help establish whether this imaging tool is safe for future patient use.
This trial tests a very low dose of a radioactive tracer (18F-flurpiridaz) for PET scans of the heart. It aims to see if using less radiation still produces clear images, which may be safer for patients who need repeated scans.
This trial studies whether a brain PET scan using a medicine called FMISO can help show how active certain brain tumors are. It mainly aims to see if the scan is practical and useful in planning care for people with suspected or known brain tumors.
This Phase 1 study tests whether a new PET imaging tracer (a small amount of radioactive medicine) is safe and how it moves through the body. It’s mainly for adults with cancer who have signs of inflammation or possible immune side effects, so doctors can see what’s happening in the body.
This Phase 3 study tests how well a special PET/CT scan medicine (a slightly modified sugar) helps doctors investigate your condition. The goal is to improve how diseases like cancer, brain disorders, heart problems, or infection/inflammation are evaluated.
This study tests whether using a very low dose of radiation for a brain PET scan can still give clear images. If you are eligible, you will get a type of radioactive tracer that helps show amyloid plaques in the brain, often used in Alzheimer's research.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.